SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-28
👔
Lexeo Therapeutics, Inc.
@LXEO_InsiderForm 4 Filing: Townsend Richard Nolan Acquires (Grant) $6K of $LXEO
STOCK AWARD / GRANT
⚡ MATERIALITY: 3/10
corporate issuer
Lexeo Therapeutics, Inc.
Ticker: $LXEO
Transaction Value
$6K
Price/Share: $2.64
transaction date
2026-09-14
Shares: 2,306
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Townsend Richard Nolan, holds the title of Chief Executive Officer at Lexeo Therapeutics, Inc..
On 2026-09-14, the insider transacted 2,306 shares.The shares were transacted at a weighted average price of $2.64 per share, resulting in a total market-relevant value of $6K.
Executive Summary Summary
Townsend Richard Nolan (Chief Executive Officer) was granted $6K of $LXEO
Post-Transaction Position: 376,778 shares
SEC Accession No: 0001995218-26-000017 (CIK: 1995218)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.